Certified by Founder Lodge
TigerGene LLC
United States - Cambridge
INVESTOR
1 Disclosed Funding Rounds $30,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
A venture capital fund that invests in the most promising early stage life science technologies.
| Company | Date | Round | Raised |
|---|---|---|---|
 Valora Therapeutics, Inc. |
November, 21 ,2024 | Seed | $30,000,000 |
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Transition Metal Solutions | $6,000,000 | (Jan 20, 2026)
Tulip Interfaces | $120,000,000 | (Jan 20, 2026)
Fanvue | $22,000,000 | (Jan 20, 2026)
Gutology | $2,418,300 | (Jan 20, 2026)
Fleetzero | $43,000,000 | (Jan 20, 2026)
